Monday, September 7, 2026

@bigpoppad66 i’ve invested in a bunch and would love nothing more than to lever into $TSLA on real optimus traction, meaning capabilities of the hardware, that i have yet to see or hear about from my network

@leevalueroach Sep 7 2 clicks

Lee Roach on X

I think I’ll do a deep dive on $FICO. I get they lost their monopoly by neop baby Bill Pulte but Jeeze this is low. https://t.co/g43xw6Lu1c

@ChrisCamillo Sep 7 2 clicks

Chris Camillo on X

@RajDuncan @topazbenj @tslaming @Jason i have my channels on intel and when i’m convinced ill go all in on $TSLA. i sincerely want every company in the sector to succeed as its a net positive for humanity.

@ChrisCamillo Sep 7 2 clicks

Chris Camillo on X

@topazbenj @RajDuncan @tslaming That is factually wrong and not how I invest. One of my top future opportunities is a levered long $TSLA trade the second I identify meaningful positive traction in Optimus. important not to become emotionally attached to stocks or your any thesis

@leevalueroach Sep 7

Lee Roach on X

Growth investors who bought Nike $NKE at a 0.05% free cash flow yield at the peak. https://t.co/onptAiCXtu

@leevalueroach Sep 7 2 clicks

Lee Roach on X

@JacobWolinsky Yeah it was so hyped I didn't even bother to read it. Might read it now that $NKE is crashing.

@leevalueroach Sep 7 3 clicks

Lee Roach on X

I remember back in the day all of the growth investors and VC dorks were talking up this book so much. It was literally the Bible for growth investors. But now that $NKE is in the dumps and the stock has cratered I don't see anyone diving in here trying to buy this company on the cheap. But I guess when it had a 1% free cash flow yield that was all good.

On Holding $ONON: I Bought the Shoes First, Then the Stock

On Holding $ONON combines a high-margin direct-to-consumer footwear model with replacement-driven demand, after Q2 2026 sales rose 21.6%…

ONON $9.9B

Substack von Philipp Sep 7 5 clicks

Preview of the Week Ahead: W/C September 7, 2026

U.S. CPI and PPI headline the September 7 week as the S&P 500 holds key averages, Bitcoin faces $82,000 resistance and gold tests its…

AMZN $2.8TCOIN $51B

SixSigmaCapital: Navigating the Financial Markets Sep 6 2 clicks

AppLovin Deep Dive: Not A No Brainer

AppLovin is down 48% YTD after its first guidance miss, with revenue 1% below expectations and EPS 2.5% short, reviving fears of an adtech…

APP $104B

Capitalist Letters Sep 6 6 clicks

RBC Bearings Has Fallen Enough To Shift Gears (Rating Upgrade)

RBC Bearings' Q1 2027 revenue rose 19.2% and net income 48.2%, while a $2.3 billion backlog driven by aerospace and defense supports growth…

RBC $16B

Daniel Jones Sep 6 1 click

Amazon’s AI Economics

Amazon combines AWS AI infrastructure, model-company stakes and retail automation, with AWS targeting $1 trillion in annual revenue over…

AMZN $2.8T

Modern Value Investing Sep 6 7 clicks

When Anyone Can Make a Movie, Netflix Still Wins

Netflix’s roughly $20 billion content budget can become an editorial advantage as generative AI cuts production costs and floods viewers…

NFLX $511B

Bearhold Research Sep 5 8 clicks

Wells Fargo: Stick To High-Yield Preferred Shares During Interest Rate Volatility

Wells Fargo Series L preferred shares yield 6.55%, with preferred dividends consuming 4% of Q2 2026 profit and no call risk.

WFC $262B

The Investment Doctor Sep 5 1 click

Bypassing RevenueBench to Buy the Feedback Loop

Meta’s free model strategy lifted OpenCode token share from 25% to 40%, building coding-data feedback loops and reducing reliance on…

META $1.7T

MBI Deep Dives Sep 5 2 clicks

Innodata: Expensive Today But The Growth Story Is Getting Stronger (Rating Upgrade)

Innodata's Q2 2026 revenue rose 58% to $92.1 million as AI datasets lifted margins, though two clients still supplied 71% of sales.

INOD $2.1B

Investor Overview Sep 5 1 click

Is OpenAI the Achilles’ Heel of the US Economy? | The Weekly Wrap

OpenAI's potential failure could expose the US economy's growing dependence on AI capital spending, according to Steve Eisman.

NVDA $5.4TMETA $1.7T

Steve Eisman Sep 4 18 clicks

BCO · long

Brinks CO

Brink’s $6.6 billion cash-and-stock acquisition of NCR Atleos underpins the long case, citing strategic and financial rationale.

BCO $4.4B

Value Investors Club May 8 1 click

AngelAlign - Chinese clear aligners (6699 HK)

AngelAlign holds 3% of global clear aligners and sells about HK$10,000 below Invisalign in Hong Kong, alongside speculation that MBK could…

ALGN $11B

Healthy Stock Picks Sep 22

MNST Trading Below $53 Offers Nearly Risk-Free Return

Monster Beverage’s modified Dutch auction lets odd-lot holders buy 99 MNST shares below $53 and tender them at $53 to $60.

MNST $86B

Rod’s Ruminations May 23

Some Thoughts on Roaring Kitty

Roaring Kitty’s GameStop resurgence revisits GME shareholder activism and the meme-stock trading episode, with references to Bed Bath &…

GME $12B

Rod’s Ruminations May 21

(C)riminally (V)alued (S)caled Healthcare Services

CVS Health fell 20% after cutting 2024 adjusted EPS guidance to $7, but its Aetna insurance and Caremark PBM businesses support a…

CVS $111B

Rod’s Ruminations May 1

Sarepta Risk and the FDA

Sarepta’s Exondys 51 approval despite a 12-patient trial frames FDA regulatory risk and a call to remove Commissioner Robert Califf.

SRPT $2.2B

John Hempton's Newsletter Oct 31 1 click

A Value Trap, an Ancient Stock Pitch, a Glimpse Into The Past

Four Corners’ insider-backed asset sale cut shareholder proceeds to roughly 80% of its prior share price. A 2016 Wilh.

FCPT $2.7B

Exploring with Alluvial Capital Sep 27

Does anyone remember when Alnylam went up 50 percent in a day on a phase three result

Alnylam’s 2022 50% phase-three gain faces FDA advisory-panel scrutiny over its amyloidosis drug’s label extension.

ALNY $33B

John Hempton's Newsletter Sep 12

We can get some extra votes. Pity they are worthless and scumbags are in charge of governance.

Campari’s five-year loyalty plan grants five votes per share, letting its controlling shareholder sell stock while retaining control and…

DVCMY $8.1B

John Hempton's Newsletter Aug 7 1 click

Value Roundup

Talen’s post-bankruptcy nuclear assets, FREIT’s $22 Kushner bid and Calithera’s failed liquidation vote illustrate unusual small-cap…

TLN $14B

Exploring with Alluvial Capital Jul 5

Monday, September 7, 2026

Prepared Remarks on X

Chris Camillo on X

Lee Roach on X

Chris Camillo on X

Chris Camillo on X

Lee Roach on X

Lee Roach on X

Lee Roach on X

Investor Letters

Publications we follow

Newsletters 91

YouTube 4

Blogs 12

Seeking Alpha 29 of 161

X accounts we follow

Investor letters we follow

Sectors